Funding

State House News Service reporter Katie Castellani writes that President Sally Kornbluth and Governor Maura Healey announced a new shared-use quantum facility at MIT, the Quantum Systems Laboratory (QSL), aimed at providing scientists the opportunity to apply quantum research across various sectors, including defense and the life sciences. The QSL will “bring quantum computers together with quantum sensors and peripherals through physical channels that transfer information,” Castellani explains. 

The Economist reports on the growing popularity of ingestible sensors, including work at MIT where researchers are using the devices to “sense internal conditions and act on what they find.”  The MIT team “received $66m from ARPA-H, a federal grant system that pushes high-risk, transformative health-care technology, to develop ingestible devices for the oral delivery of mRNA treatments.” 

Writing for The Boston Globe, President Sally Kornbluth emphasizes the importance of investment in discovery science, what she calls “curiosity on a mission." Kornbluth notes: “When someone we love needs therapies that could have emerged but didn’t or when other countries now investing in science can launch new science-based industries or run their societies on vast resources of fusion energy or reap the benefits of quantum computing power or advanced medical breakthroughs, America will wish it sustained its leadership in scientific research here and now.”

President Emeritus L. Rafael Reif joins Rob Schmitz of NPR’s All Things Considered about how the U.S. can regain its edge as the global leader in science and innovation. Reif makes the case for investing in basic research in the country, and finding “a way so that the innovative ideas coming out of our labs don't end up in another country like China, that we develop them here by giving them a longer runway for them to materialize and make an impact.”

President Sally Kornbluth joined Lizzie O’Leary of Slate’s "What Next: TBD" podcast for a live discussion, during which she stressed the importance of curiosity-driven science and emphasized why basic science is critical to our nation’s future. “If you think about long pathways, like immunotherapy for cancer, that began 30-40-years ago in basic immunotherapy research,” said Kornbluth. She added: “As one of the top institutions in the world it’s part of our responsibility to articulate the importance of science.” 

The Advanced Research Projects Agency for Health (ARPA-H) is providing funding for the Ocular Laboratory for Analysis of Biomarkers (OCULAB), which includes researchers from MIT and "will initially focus on dry eye disease that affects more than 20 million people in the United States,” reports Alison Kuznitz at State House News Service. The MIT team is "building sensors to detect biomarkers of dry eye disease and diabetes,” writes Kuznitz. 

Boston Globe reporter Jon Chesto spotlights the MIT Martin Trust Center for MIT Entrepreneurship’s delta v startup accelerator program, which is designed to help early-stage startups find success in the Boston area. With financial support from Klaviyo co-founders Ed Hallen MBA ’12, and Andrew Bialecki, the program will “help support more customizing, to better tailor the program for each entrepreneur, as well as a broadening of its professional network, to support mentorship from industry veterans for the participating startups,” writes Chesto. 

MIT President Sally Kornbluth joined Jim Braude and Margery Eagan live in studio for GBH’s Boston Public Radio to discuss MIT, the pressures facing America’s research enterprise, the importance of science and more. 

Prof. Pierre Azoulay speaks with WBUR’s Martha Bebinger about a new study examining the potential impact of NIH budget cuts on the development of new medicines. Azoulay and his colleagues found that “more than half of drugs approved by the FDA since 2000 used NIH-funded research that would likely not have happened if the NIH had operated with a 40% smaller budget,” Bebinger explains. 

Fierce Biotech reporter Darren Incorvaia writes that a new study by MIT researchers demonstrates how potential NIH budget cuts could endanger the development of new medications. The researchers found that if the NIH budget had been 40% smaller from 1980 to 2007, the level of NIH cuts currently being proposed, “the science underlying numerous drugs approved in the 21st century would not have been funded,” Incorvaia explains. The findings suggest that “massive cuts of the kind that are being contemplated right now could endanger the intellectual foundations of the drugs of tomorrow,” explains Professor Pierre Azoulay. 

A new study co-authored by MIT researchers finds that more than half of the drugs approved by the FDA since 2000 are connected to NIH research that would be impacted by proposed 40 percent budget cuts, reports Genetic Engineering & Biotechnology News. 

President Emeritus L. Rafael Reif joins Bloomberg’s Wall Street Week to highlight the importance of university research for the U.S. economy. “The federal government funds research at universities,” begins Reif. “Scientific research advances knowledge. And we do it here. And at the same time we educate the leaders of the future, who bring that advanced knowledge into the marketplace. That has been at the heart of the terrific ecosystem of innovation in this country.” He adds: “We have benefitted in the past 80 years from this terrific system, and not having access to that is going to basically kill the source of ideas that will power our economy for the next 80 years.” 

Boston Globe reporter Jon Chesto spotlights the kickoff event for the new MIT-GE Vernova Energy and Climate Alliance, which will “fund research initiatives, fellowships, and other programs with an eye toward improving energy technologies and decarbonization.” GE Vernova CEO Scott Strazik emphasized that he has been impressed with the passion and talent for clean-tech among the students at MIT and other universities. “I started these discussions with the objective that we should inspire future leaders to come into our industry and ideally come to our company,” Strazik said. “They’ve probably inspired us more than we’ve inspired them.”

Writing for The New York Times, Prof. David Autor and Prof. Gordon Hanson of Harvard explore how China is “aggressively contesting the innovative sectors where the United States has long been the unquestioned leader." To avoid a second China Shock, they emphasize that the United States “must nourish industries that have high potential for innovation, funded by joint investments by the private and public sectors.” 

Writing for The Boston Globe, President Emeritus L. Rafael Reif examines how the proposed endowment tax on colleges and universities will likely “raise the cost of a college education and hurt US competitiveness.” Reif notes that universities use income from their endowments to provide financial aid for students and support research. “Without financial aid, students from less wealthy backgrounds would not be able to attend the country’s great private universities,” writes Reif. “This would be not just a loss to them but also to the nation itself, which benefits when talented people from all backgrounds have the same opportunity to rise based on academic achievement.”